Gene expression linked to colorectal cancer progression such as EGFR, TGFB1, transforming growth factor-β receptor 2 (TGFBR2), and tumor protein 53 (TP53) and growth factor pathways were significantly reduced by combined treatment of heteronemin and tetrac [11]. Here, TP53 is linked to colorectal cancer.